BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,503,604 | +3765.0% | 251,818 | +4565.9% | 0.03% | +933.3% |
Q2 2023 | $245,890 | +16.3% | 5,397 | +3.5% | 0.00% | +50.0% |
Q1 2023 | $211,434 | -97.0% | 5,213 | -95.3% | 0.00% | -98.0% |
Q2 2022 | $7,156,000 | +2785.5% | 109,788 | +3525.8% | 0.10% | +2400.0% |
Q3 2021 | $248,000 | +1.2% | 3,028 | +0.3% | 0.00% | 0.0% |
Q2 2021 | $245,000 | -3.5% | 3,018 | +1.0% | 0.00% | -20.0% |
Q1 2021 | $254,000 | +2.4% | 2,987 | -3.6% | 0.01% | -16.7% |
Q4 2020 | $248,000 | -90.7% | 3,099 | -90.8% | 0.01% | -91.4% |
Q3 2020 | $2,679,000 | -0.1% | 33,643 | +11.9% | 0.07% | -9.1% |
Q2 2020 | $2,681,000 | -43.3% | 30,060 | -42.1% | 0.08% | -54.4% |
Q1 2020 | $4,725,000 | +150.4% | 51,923 | +136.6% | 0.17% | +103.6% |
Q2 2019 | $1,887,000 | +109.2% | 21,947 | +59.9% | 0.08% | +36.1% |
Q1 2018 | $902,000 | -2.3% | 13,722 | -6.5% | 0.06% | -19.7% |
Q3 2017 | $923,000 | +39.0% | 14,679 | +5.9% | 0.08% | -23.2% |
Q3 2016 | $664,000 | – | 13,866 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |